Skip to main content

Table 3 Activity counts per 6 h (mean ± SD), measured the second night and day in the two intervention groups

From: Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

 

Baseline

Follow-up

Paired samples t-test

 

N = 11 (Melatonin) N = 19 (Placebo)

N = 11 (Melatonin) N = 19 (Placebo)

   
   

t

df

P

1–6 h after wake up time

 Melatonin

58798 ± 26310

72697 ± 37957

−1.490

10

0.167

 Placebo

48444 ± 31383

60822 ± 32990

−1.335

18

0.198

7–12 h after wake up time

 Melatonin

67643 ± 22202

92526 ± 45319

−1.441

10

0.180

 Placebo

54276 ± 37688

64314 ± 33724

−0.909

18

0.376

13–18 h after wake up time

 Melatonin

37399 ± 17875

48155 ± 23070

−1.088

10

0.320

 Placebo

34578 ± 32279

38500 ± 36509

−0.341

18

0.737

19–24 h after wake up time

 Melatonin

6854 ± 5466

7046 ± 7347

−0.087

10

0.933

 Placebo

9332 ± 10308

15341 ± 15071

−1.447

18

0.165

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us